127 related articles for article (PubMed ID: 35637134)
21. Ground-glass opacity lesions on computed tomography during postoperative surveillance for primary non-small cell lung cancer.
Haro A; Yano T; Kohno M; Yoshida T; Okamoto T; Maehara Y
Lung Cancer; 2012 Apr; 76(1):56-60. PubMed ID: 21945659
[TBL] [Abstract][Full Text] [Related]
22. Surgery versus stereotactic body radiotherapy for clinical stage I non-small-cell lung cancer: propensity score-matching analysis including the ratio of ground glass nodules.
Tomita N; Okuda K; Osaga S; Miyakawa A; Nakanishi R; Shibamoto Y
Clin Transl Oncol; 2021 Mar; 23(3):638-647. PubMed ID: 32705493
[TBL] [Abstract][Full Text] [Related]
23. Five-year Long-term Outcomes of Stereotactic Body Radiation Therapy for Operable Versus Medically Inoperable Stage I Non-small-cell Lung Cancer: Analysis by Operability, Fractionation Regimen, Tumor Size, and Tumor Location.
Schonewolf CA; Heskel M; Doucette A; Singhal S; Frick MA; Xanthopoulos EP; Corradetti MN; Friedberg JS; Pechet TT; Christodouleas JP; Levin W; Berman A; Cengel KA; Verma V; Hahn SM; Kucharczuk JC; Rengan R; Simone CB
Clin Lung Cancer; 2019 Jan; 20(1):e63-e71. PubMed ID: 30337269
[TBL] [Abstract][Full Text] [Related]
24. Clinical, pathological and thin-section CT features of persistent multiple ground-glass opacity nodules: comparison with solitary ground-glass opacity nodule.
Kim TJ; Goo JM; Lee KW; Park CM; Lee HJ
Lung Cancer; 2009 May; 64(2):171-8. PubMed ID: 18799230
[TBL] [Abstract][Full Text] [Related]
25. Factors affecting local control of pulmonary oligometastases treated with stereotactic body radiotherapy.
Sharma A; Duijm M; Oomen-de Hoop E; Aerts JG; Verhoef C; Hoogeman M; Nuyttens JJ
Acta Oncol; 2018 Aug; 57(8):1031-1037. PubMed ID: 29488414
[TBL] [Abstract][Full Text] [Related]
26. CT Appearance Pattern After Stereotactic Body Radiation Therapy Predicts Outcomes in Early-Stage Non-Small-Cell Lung Cancer.
Yang Y; Li G; Li S; Wang Y; Zhao Y; Dong B; Wang J; Zhu R; Chen M
Front Oncol; 2021; 11():746785. PubMed ID: 34707992
[TBL] [Abstract][Full Text] [Related]
27. Histology of non-small cell lung cancer predicts the response to stereotactic body radiotherapy.
Hörner-Rieber J; Bernhardt D; Dern J; König L; Adeberg S; Paul A; Heussel CP; Kappes J; Hoffmann H; Herth FJP; Debus J; Warth A; Rieken S
Radiother Oncol; 2017 Nov; 125(2):317-324. PubMed ID: 28919006
[TBL] [Abstract][Full Text] [Related]
28. Quantitative CT Scanning Analysis of Pure Ground-Glass Opacity Nodules Predicts Further CT Scanning Change.
Bak SH; Lee HY; Kim JH; Um SW; Kwon OJ; Han J; Kim HK; Kim J; Lee KS
Chest; 2016 Jan; 149(1):180-91. PubMed ID: 26313232
[TBL] [Abstract][Full Text] [Related]
29. Lung density changes after stereotactic radiotherapy: a quantitative analysis in 50 patients.
Palma DA; van Sörnsen de Koste J; Verbakel WF; Vincent A; Senan S
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):974-8. PubMed ID: 20932655
[TBL] [Abstract][Full Text] [Related]
30. [A Case of New Rapidly Progressing Ground-glass Nodule Lung Adenocarcinoma Near Primary Lesion after Stereotactic Body Radiation Therapy].
Wang S; Li L; Cheng Y
Zhongguo Fei Ai Za Zhi; 2024 Jan; 26(12):957-960. PubMed ID: 38163982
[TBL] [Abstract][Full Text] [Related]
31. Ground-glass opacity nodules: histopathology, imaging evaluation, and clinical implications.
Lee HY; Lee KS
J Thorac Imaging; 2011 May; 26(2):106-18. PubMed ID: 21508733
[TBL] [Abstract][Full Text] [Related]
32. High-dose stereotactic body radiotherapy correlates increased local control and overall survival in patients with inoperable hepatocellular carcinoma.
Jang WI; Kim MS; Bae SH; Cho CK; Yoo HJ; Seo YS; Kang JK; Kim SY; Lee DH; Han CJ; Kim J; Park SC; Kim SB; Cho EH; Kim YH
Radiat Oncol; 2013 Oct; 8():250. PubMed ID: 24160944
[TBL] [Abstract][Full Text] [Related]
33. Impact of pretreatment whole-tumor perfusion computed tomography and 18F-fluorodeoxyglucose positron emission tomography/computed tomography measurements on local control of non-small cell lung cancer treated with stereotactic body radiotherapy.
Aoki M; Akimoto H; Sato M; Hirose K; Kawaguchi H; Hatayama Y; Seino H; Kakehata S; Tsushima F; Fujita H; Fujita T; Fujioka I; Tanaka M; Miura H; Ono S; Takai Y
J Radiat Res; 2016 Sep; 57(5):533-540. PubMed ID: 27296251
[TBL] [Abstract][Full Text] [Related]
34. Predictive value of one-dimensional mean computed tomography value of ground-glass opacity on high-resolution images for the possibility of future change.
Tamura M; Shimizu Y; Yamamoto T; Yoshikawa J; Hashizume Y
J Thorac Oncol; 2014 Apr; 9(4):469-72. PubMed ID: 24736068
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of ground-glass opacity found in small lung adenocarcinoma on high-resolution CT scanning.
Kodama K; Higashiyama M; Yokouchi H; Takami K; Kuriyama K; Mano M; Nakayama T
Lung Cancer; 2001 Jul; 33(1):17-25. PubMed ID: 11429192
[TBL] [Abstract][Full Text] [Related]
36. Assessing the usefulness of 18F-fluorodeoxyglucose PET-CT scan after stereotactic body radiotherapy for early-stage non-small cell lung cancer.
Pastis NJ; Greer TJ; Tanner NT; Wahlquist AE; Gordon LL; Sharma AK; Koch NC; Silvestri GA
Chest; 2014 Aug; 146(2):406-411. PubMed ID: 24577678
[TBL] [Abstract][Full Text] [Related]
37. Stereotactic Body Radiation Therapy for Non-Small Cell Lung Cancer Tumors Greater Than 5 cm: Safety and Efficacy.
Woody NM; Stephans KL; Marwaha G; Djemil T; Videtic GM
Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):325-31. PubMed ID: 25841625
[TBL] [Abstract][Full Text] [Related]
38. Relationship between the consolidation to maximum tumor diameter ratio and outcomes following stereotactic body radiotherapy for stage I non-small-cell lung cancer.
Tsurugai Y; Kozuka T; Ishizuka N; Oguchi M
Lung Cancer; 2016 Feb; 92():47-52. PubMed ID: 26775596
[TBL] [Abstract][Full Text] [Related]
39. Recurrence Patterns and Second Primary Lung Cancers After Stereotactic Body Radiation Therapy for Early-Stage Non-Small-Cell Lung Cancer: Implications for Surveillance.
Spratt DE; Wu AJ; Adeseye V; Din SU; Shaikh F; Woo KM; Zhang Z; Foster A; Rosenzweig KE; Gewanter R; Huang J; Rimner A
Clin Lung Cancer; 2016 May; 17(3):177-183.e2. PubMed ID: 26602271
[TBL] [Abstract][Full Text] [Related]
40. Short-term outcomes and clinical efficacy of stereotactic body radiation therapy (SBRT) in treatment of adrenal gland metastases from lung cancer.
Zhao X; Zhu X; Fei J; Ren H; Cao Y; Ju X; Yuan Z; Zhang H
Radiat Oncol; 2018 Oct; 13(1):205. PubMed ID: 30348187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
